Screener
AnaptysBio, Inc. ANAB Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | March 31, 2026(unaudited) | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000 shares authorized and no shares, issued or outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Common stock, $0.001 par value, 500,000 shares authorized, 29,031 shares and 28,019 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 29 | 28 |
| Additional paid-in capital | 838,307 | 809,765 |
| Accumulated other comprehensive loss | (146) | (24) |
| Accumulated deficit | (825,443) | (772,559) |
| Total stockholders’ equity | 12,747 | 37,210 |
| Total liabilities and stockholders’ equity | $329,684 | $364,395 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s retained earnings?
- AnaptysBio, Inc. (ANAB) reported retained earnings of -$825.44M in Q1 2026.
- How has AnaptysBio, Inc.'s retained earnings changed year-over-year?
- AnaptysBio, Inc.'s retained earnings decreased by 3.4% year-over-year, from -$798.66M to -$825.44M.
- What is the long-term trend for AnaptysBio, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s retained earnings has grown at a 24.0% compound annual growth rate (CAGR), from -$263.96M to -$772.56M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about AnaptysBio, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude